5AM Venture Management

Latest statistics and disclosures from 5AM Venture Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ELVN, TRDA, PHVS, CLDX, MLTX, and represent 52.61% of 5AM Venture Management's stock portfolio.
  • Added to shares of these 6 stocks: BHVN (+$17M), MRUS (+$14M), CLDX (+$7.4M), PHVS (+$5.9M), VRDN, TYRA.
  • Started 2 new stock positions in MRUS, BHVN.
  • Reduced shares in these 5 stocks: CRNX (-$14M), IRON (-$8.3M), ARVN (-$6.3M), IMPLQ, MLTX.
  • Sold out of its positions in ARVN, CRNX, IMPLQ.
  • 5AM Venture Management was a net buyer of stock by $20M.
  • 5AM Venture Management has $377M in assets under management (AUM), dropping by 8.47%.
  • Central Index Key (CIK): 0001799883

Tip: Access up to 7 years of quarterly data

Positions held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for 5AM Venture Management

5AM Venture Management holds 25 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Enliven Therapeutics (ELVN) 18.9 $71M 5.2M 13.84
 View chart
Entrada Therapeutics (TRDA) 17.6 $67M 4.4M 15.09
 View chart
Pharvaris N V (PHVS) 5.9 $22M +35% 798k 28.05
 View chart
Celldex Therapeutics Com New (CLDX) 5.2 $20M +60% 497k 39.66
 View chart
Moonlake Immunotherapeutics Class A Ord (MLTX) 4.8 $18M -3% 303k 60.39
 View chart
Biohaven (BHVN) 4.5 $17M NEW 400k 42.80
 View chart
Disc Medicine (IRON) 4.5 $17M -32% 294k 57.76
 View chart
Dianthus Therapeutics (DNTH) 4.1 $15M 1.5M 10.40
 View chart
Merus N V (MRUS) 3.8 $14M NEW 522k 27.50
 View chart
Vor Biopharma (VOR) 3.8 $14M 6.4M 2.25
 View chart
Miragen Therapeutics (VRDN) 3.4 $13M +43% 587k 21.78
 View chart
Mirati Therapeutics (MRTX) 3.0 $11M 193k 58.75
 View chart
Viking Therapeutics (VKTX) 2.9 $11M 585k 18.61
 View chart
Rallybio Corp (RLYB) 2.3 $8.7M 3.6M 2.39
 View chart
Tyra Biosciences (TYRA) 2.0 $7.7M +34% 555k 13.85
 View chart
Anaptysbio Inc Common (ANAB) 2.0 $7.7M 358k 21.42
 View chart
Scpharmaceuticals (SCPH) 2.0 $7.5M 1.2M 6.27
 View chart
Zentalis Pharmaceuticals (ZNTL) 2.0 $7.4M 490k 15.15
 View chart
Spruce Biosciences (SPRB) 1.8 $6.9M 2.4M 2.93
 View chart
Avidity Biosciences Ord (RNA) 1.6 $6.0M 666k 9.05
 View chart
Cogent Biosciences (COGT) 1.2 $4.6M 790k 5.88
 View chart
Mersana Therapeutics (MRSN) 0.8 $3.0M 1.3M 2.32
 View chart
Homology Medicines (FIXX) 0.7 $2.8M 4.5M 0.61
 View chart
Gh Research Ordinary Shares (GHRS) 0.6 $2.3M 404k 5.80
 View chart
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) 0.2 $901k 1.1M 0.79
 View chart

Past Filings by 5AM Venture Management

SEC 13F filings are viewable for 5AM Venture Management going back to 2019